TOMEI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 502
EU - Europa 486
AS - Asia 162
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.154
Nazione #
US - Stati Uniti d'America 501
GB - Regno Unito 184
CN - Cina 125
SE - Svezia 83
IT - Italia 58
FR - Francia 40
IE - Irlanda 35
FI - Finlandia 29
VN - Vietnam 29
DE - Germania 28
BE - Belgio 10
AT - Austria 9
UA - Ucraina 6
TR - Turchia 4
AR - Argentina 2
EU - Europa 2
RU - Federazione Russa 2
CA - Canada 1
IL - Israele 1
ME - Montenegro 1
NL - Olanda 1
SA - Arabia Saudita 1
SG - Singapore 1
TW - Taiwan 1
Totale 1.154
Città #
Southend 154
Chandler 125
Ann Arbor 67
Jacksonville 51
Woodbridge 37
Dublin 35
Ashburn 34
Dong Ket 23
Beijing 20
Houston 20
Wilmington 18
Jinan 16
Lawrence 16
Princeton 16
Lancaster 14
Shenyang 14
Jiaxing 11
Verona 11
Brussels 10
Nanjing 9
Vienna 9
Taizhou 7
Boardman 6
Ningbo 6
Hebei 5
San Francisco 5
Taiyuan 5
Tianjin 5
Cagliari 4
Foggia 4
New York 4
Detroit 3
Haikou 3
Helsinki 3
Milan 3
Nanchang 3
Padova 3
Washington 3
Zhengzhou 3
Auburn Hills 2
Lanzhou 2
Norwalk 2
Seattle 2
Venice 2
Austin 1
Changsha 1
Clearwater 1
Des Moines 1
Düsseldorf 1
Edinburgh 1
Falls Church 1
Fuzhou 1
Groningen 1
Guangzhou 1
Hangzhou 1
Jeffries 1
London 1
Los Angeles 1
Malo 1
Newark 1
Nürnberg 1
Podgorica 1
Reston 1
Riyadh 1
Scandicci 1
Simi Valley 1
Sindelfingen 1
Singapore 1
Taipei 1
Tappahannock 1
Toronto 1
Totale 822
Nome #
mTOR inhibitors and renal allograft: Yin and Yang. 97
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 97
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 95
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 86
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 84
Post-renal transplant pregnancy: a project to plan carefully 78
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 78
Individuazione di nuovi marker diagnostici e target terapeutici potenzialmente utilizzabili nella pratica clinica trapiantologica per minimizzare il processo di fibrosi polmonare indotta dalle alte dosi di everolimus: risultati di uno studio in vitro di mirnomica e trascrittomica. 78
Unusual renal presentation of Fabry disease in a female patient. 71
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 71
Mitochondria: a new therapeutic target in chronic kidney disease. 70
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 67
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 66
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 65
Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients 59
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 44
Totale 1.206
Categoria #
all - tutte 3.413
article - articoli 3.193
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 220
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 4 4 1
2019/2020150 21 6 0 11 13 16 21 4 12 33 6 7
2020/2021161 20 41 4 12 17 11 5 4 1 3 11 32
2021/2022147 7 29 3 32 2 3 9 8 3 4 7 40
2022/2023323 26 58 28 53 26 73 0 11 34 1 11 2
2023/202486 6 13 10 5 12 24 2 12 2 0 0 0
Totale 1.206